These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 7597317)

  • 1. [Mechanisms of cardiac involvement in systemic scleroderma. Apropos of 3 cases].
    Milesi-Lecat AM; Aumaitre O; Schmidt J; Cauhapé PH; Kémény JL; Francès C; Marcaggi X; Peycelon P; Lusson JR; Marcheix JC
    Rev Med Interne; 1995; 16(5):319-24. PubMed ID: 7597317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Mechanisms of cardiac involvement in systemic scleroderma, apropos of 3 cases].
    Milesi-Lecat AM; Cauhape P; Schmidt J; Marcaggi X; Peycelon P; Kemeny JL; Lusson JR; Frances C; Marcheix JC; Aumaitre O
    Rev Med Interne; 1993; 14(10):936. PubMed ID: 8009038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary myocardial involvement in systemic sclerosis.
    Kahan A; Allanore Y
    Rheumatology (Oxford); 2006 Oct; 45 Suppl 4():iv14-7. PubMed ID: 16980717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physiologic abnormalities of cardiac function in progressive systemic sclerosis with diffuse scleroderma.
    Follansbee WP; Curtiss EI; Medsger TA; Steen VD; Uretsky BF; Owens GR; Rodnan GP
    N Engl J Med; 1984 Jan; 310(3):142-8. PubMed ID: 6690931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cardiac involvement in scleroderma].
    Olivares LM; Gatti JC; Romorini A; Chwojnik A; Cardama JE; Pizarielo GE
    Med Cutan Ibero Lat Am; 1988; 16(6):481-8. PubMed ID: 3073274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Myocardial tomoscintigraphy with 201Tl in the diagnosis of cardiac involvement in systemic scleroderma].
    Samoĭlenko LE; Bogdanov AP; Moiseev SV; Guseva NG; Pshenitsyn AI; Pasha SP; Sergienko VB
    Ter Arkh; 1996; 68(5):30-3. PubMed ID: 9082594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversible cold-induced abnormalities in myocardial perfusion and function in systemic sclerosis.
    Alexander EL; Firestein GS; Weiss JL; Heuser RR; Leitl G; Wagner HN; Brinker JA; Ciuffo AA; Becker LC
    Ann Intern Med; 1986 Nov; 105(5):661-8. PubMed ID: 3767147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cardiovascular involvement in systemic sclerosis].
    Constans J; Skopinski S; Barcat D; Conri C
    Ann Med Interne (Paris); 2002 Jun; 153(4):242-9. PubMed ID: 12218890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced coronary flow and resistance reserve in primary scleroderma myocardial disease.
    Nitenberg A; Foult JM; Kahan A; Perennec J; Devaux JY; Menkes CJ; Amor B
    Am Heart J; 1986 Aug; 112(2):309-15. PubMed ID: 3739882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of captopril on thallium 201 myocardial perfusion in systemic sclerosis.
    Kahan A; Devaux JY; Amor B; Menkès CJ; Weber S; Venot A; Strauch G
    Clin Pharmacol Ther; 1990 Apr; 47(4):483-9. PubMed ID: 2183960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Changes in the heart in progressive systemic sclerosis].
    Lipa I; Cerimović S; Mahić-Zikić A; Sedlar I
    Reumatizam; 1986; 33(1-2):11-7. PubMed ID: 3797851
    [No Abstract]   [Full Text] [Related]  

  • 12. Primary myocardial involvement in systemic sclerosis: evidence for a microvascular origin.
    Allanore Y; Meune C
    Clin Exp Rheumatol; 2010; 28(5 Suppl 62):S48-53. PubMed ID: 21050545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nifedipine and thallium-201 myocardial perfusion in progressive systemic sclerosis.
    Kahan A; Devaux JY; Amor B; Menkès CJ; Weber S; Nitenberg A; Venot A; Guérin F; Degeorges M; Roucayrol JC
    N Engl J Med; 1986 May; 314(22):1397-402. PubMed ID: 3486363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased coronary reserve in primary scleroderma myocardial disease.
    Kahan A; Nitenberg A; Foult JM; Amor B; Menkes CJ; Devaux JY; Blanchet F; Perennec J; Lutfalla G; Roucayrol JC
    Arthritis Rheum; 1985 Jun; 28(6):637-46. PubMed ID: 4004974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myocardial lesions of progressive systemic sclerosis. A cause of cardiac dysfunction.
    Bulkley BH; Ridolfi RL; Salyer WR; Hutchins GM
    Circulation; 1976 Mar; 53(3):483-90. PubMed ID: 1248080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac involvement in scleroderma.
    Deswal A; Follansbee WP
    Rheum Dis Clin North Am; 1996 Nov; 22(4):841-60. PubMed ID: 8923599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Myocardial microvascularization in scleroderma].
    Kahan A; Devaux JY; Weber S; Nitenberg A; Amor B; Menkes CJ; Guerin F; Degeorges M
    Arch Mal Coeur Vaiss; 1988 Apr; 81(4):495-500. PubMed ID: 3136710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Myocardial scintigraphy with thallium-201 in the diagnosis of cardiac involvement in systemic scleroderma].
    Bogdanov AP; Samoĭlenko AE; Moiseev SV; Guseva NG
    Ter Arkh; 1995; 67(5):61-3. PubMed ID: 7638784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early Detection of Cardiac Involvement in Systemic Sclerosis: The Added Value of Magnetic Resonance Imaging.
    Gargani L; Todiere G; Guiducci S; Bruni C; Pingitore A; De Marchi D; Bellando Randone S; Aquaro GD; Bazzichi L; Mosca M; Lombardi M; Pepe A; Matucci-Cerinic M; Picano E
    JACC Cardiovasc Imaging; 2019 May; 12(5):927-928. PubMed ID: 30553664
    [No Abstract]   [Full Text] [Related]  

  • 20. An extensive primary myocardial fibrosis in progressive systemic sclerosis--a case report with autopsy findings.
    Yamaoki K; Yazaki Y; Matsunaga H; Ashida T; Nagai R; Ohuchi Y; Ueda S; Miyakawa Y; Kosaka K
    Jpn Circ J; 1982 Nov; 46(11):1159-65. PubMed ID: 7131708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.